Rhea-AI Summary
Bambusa Therapeutics (Nasdaq: BBTX) priced its upsized initial public offering of common stock at $16.00 per share. The company is offering 10,555,555 shares, with expected gross proceeds of $168,888,880 before underwriting discounts, commissions and other offering expenses.
Underwriters have a 30-day option to purchase up to an additional 1,583,333 shares at the offering price, less underwriting discounts and commissions. Trading on the Nasdaq Global Select Market is expected to begin October 30, 2026. The offering is expected to close November 2, 2026, subject to customary closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags